Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients
Conditions:   HIV Infections;   Tuberculosis Interventions:   Drug: Efavirenz 600mg;   Drug: Efavirenz 400mg Sponsor:   Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2020 Category: Research Source Type: clinical trials

Adjustment of Asthma Treatment in Children Based on an Indirect Hyperresponsiveness Test
Condition:   Asthma in Children Intervention:   Other: asthma treatment adjustment taking account on degree of bronchial hyperresponsiveness Sponsors:   National Institute for Tuberculosis and Lung Diseases, Poland;   The Regional Public Hospital in Lesko, Poland;   University of Rzeszow Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2020 Category: Research Source Type: clinical trials

Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Rosuvastatin 10mg;   Drug: Rifampicin;   Drug: Isoniazid;   Drug: Pyrazinamide;   Drug: Ethambutol Sponsor:   National University Hospital, Singapore Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2020 Category: Research Source Type: clinical trials

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
Conditions:   Pulmonary Disease;   Tuberculosis, Pulmonary;   Tuberculosis;   Multi Drug Resistant Tuberculosis;   Drug Sensitive Tuberculosis;   Drug-resistant Tuberculosis;   Mycobacterium Tuberculosis Infection Interventions:   Drug: TBAJ-876 10mg;   Drug: TBAJ-876 25mg;   Drug: TBAJ-876 50mg;   Drug: TBAJ-876 100mg;   Drug: TBAJ-876 200mg;   Drug: TBAJ-876 400mg;   Drug: TBAJ-876 Dose XXXmg for Food cohort;  ...
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection
Conditions:   Spinal Tuberculosis;   Mesenchymal Stem Cell Interventions:   Combination Product: Mesenchymal Stem cell + Nacl 0.9%;   Combination Product: NaCl 0.9% Sponsor:   Ahmad Jabir Rahyussalim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
Conditions:   Pulmonary Disease;   Tuberculosis, Pulmonary;   Tuberculosis;   Multi Drug Resistant Tuberculosis;   Drug Sensitive Tuberculosis;   Drug-resistant Tuberculosis;   Mycobacterium Tuberculosis Infection Interventions:   Drug: TBAJ-876 10mg;   Drug: TBAJ-876 25mg;   Drug: TBAJ-876 50mg;   Drug: TBAJ-876 100mg;   Drug: TBAJ-876 200mg;   Drug: TBAJ-876 400mg;   Drug: TBAJ-876 Dose XXXmg for Food cohort;  ...
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection
Conditions:   Spinal Tuberculosis;   Mesenchymal Stem Cell Interventions:   Combination Product: Mesenchymal Stem cell + Nacl 0.9%;   Combination Product: NaCl 0.9% Sponsor:   Ahmad Jabir Rahyussalim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
Conditions:   Pulmonary Disease;   Tuberculosis, Pulmonary;   Tuberculosis;   Multi Drug Resistant Tuberculosis;   Drug Sensitive Tuberculosis;   Drug-resistant Tuberculosis;   Mycobacterium Tuberculosis Infection Interventions:   Drug: TBAJ-876 10mg;   Drug: TBAJ-876 25mg;   Drug: TBAJ-876 50mg;   Drug: TBAJ-876 100mg;   Drug: TBAJ-876 200mg;   Drug: TBAJ-876 400mg;   Drug: TBAJ-876 Dose XXXmg for Food cohort;  ...
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection
Conditions:   Spinal Tuberculosis;   Mesenchymal Stem Cell Interventions:   Combination Product: Mesenchymal Stem cell + Nacl 0.9%;   Combination Product: NaCl 0.9% Sponsor:   Ahmad Jabir Rahyussalim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
Conditions:   Pulmonary Disease;   Tuberculosis, Pulmonary;   Tuberculosis;   Multi Drug Resistant Tuberculosis;   Drug Sensitive Tuberculosis;   Drug-resistant Tuberculosis;   Mycobacterium Tuberculosis Infection Interventions:   Drug: TBAJ-876 10mg;   Drug: TBAJ-876 25mg;   Drug: TBAJ-876 50mg;   Drug: TBAJ-876 100mg;   Drug: TBAJ-876 200mg;   Drug: TBAJ-876 400mg;   Drug: TBAJ-876 Dose XXXmg for Food cohort;  ...
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection
Conditions:   Spinal Tuberculosis;   Mesenchymal Stem Cell Interventions:   Combination Product: Mesenchymal Stem cell + Nacl 0.9%;   Combination Product: NaCl 0.9% Sponsor:   Ahmad Jabir Rahyussalim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
Conditions:   Pulmonary Disease;   Tuberculosis, Pulmonary;   Tuberculosis;   Multi Drug Resistant Tuberculosis;   Drug Sensitive Tuberculosis;   Drug-resistant Tuberculosis;   Mycobacterium Tuberculosis Infection Interventions:   Drug: TBAJ-876 10mg;   Drug: TBAJ-876 25mg;   Drug: TBAJ-876 50mg;   Drug: TBAJ-876 100mg;   Drug: TBAJ-876 200mg;   Drug: TBAJ-876 400mg;   Drug: TBAJ-876 Dose XXXmg for Food cohort;  ...
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection
Conditions:   Spinal Tuberculosis;   Mesenchymal Stem Cell Interventions:   Combination Product: Mesenchymal Stem cell + Nacl 0.9%;   Combination Product: NaCl 0.9% Sponsor:   Ahmad Jabir Rahyussalim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
Conditions:   Pulmonary Disease;   Tuberculosis, Pulmonary;   Tuberculosis;   Multi Drug Resistant Tuberculosis;   Drug Sensitive Tuberculosis;   Drug-resistant Tuberculosis;   Mycobacterium Tuberculosis Infection Interventions:   Drug: TBAJ-876 10mg;   Drug: TBAJ-876 25mg;   Drug: TBAJ-876 50mg;   Drug: TBAJ-876 100mg;   Drug: TBAJ-876 200mg;   Drug: TBAJ-876 400mg;   Drug: TBAJ-876 Dose XXXmg for Food cohort;  ...
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection
Conditions:   Spinal Tuberculosis;   Mesenchymal Stem Cell Interventions:   Combination Product: Mesenchymal Stem cell + Nacl 0.9%;   Combination Product: NaCl 0.9% Sponsor:   Ahmad Jabir Rahyussalim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
Conditions:   Pulmonary Disease;   Tuberculosis, Pulmonary;   Tuberculosis;   Multi Drug Resistant Tuberculosis;   Drug Sensitive Tuberculosis;   Drug-resistant Tuberculosis;   Mycobacterium Tuberculosis Infection Interventions:   Drug: TBAJ-876 10mg;   Drug: TBAJ-876 25mg;   Drug: TBAJ-876 50mg;   Drug: TBAJ-876 100mg;   Drug: TBAJ-876 200mg;   Drug: TBAJ-876 400mg;   Drug: TBAJ-876 Dose XXXmg for Food cohort;  ...
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Identifcation of Biomarkers for Active Pulmonary Tuberculosis
Conditions:   Tuberculosis;   Diagnosis Intervention:   Other: with no intervention, Collect samples Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2020 Category: Research Source Type: clinical trials